ESCRS - J&J Vision announces availability of TECNIS Synergy IOL ;

J&J Vision announces availability of TECNIS Synergy IOL

Company introduces 'revolutionary' continuous-range-of-vision IOL

J&J Vision announces availability of TECNIS Synergy IOL
Priscilla Lynch
Priscilla Lynch
Published: Sunday, September 15, 2019
JOHNSON & Johnson Vision (JJV) invites ESCRS delegates to look at what the company describes as its “revolutionary” continuous-range-of-vision intraocular lens for patients with cataracts, which is now available in Europe, Australia and New Zealand. “TECNIS Synergy™ IOL creates a new standard in presbyopia-correcting IOL technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions,” a company spokesperson said. “With TECNIS Synergy IOL, we have created our most advanced IOL solution yet, which gives patients the clear, continuous range of vision they want, day and night,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision. “As ophthalmic pioneers, we continue to challenge ourselves on a daily basis to create solutions to the ever-changing needs of patients. Today, we stay true to our legacy of innovation with the introduction of TECNIS Synergy IOL, which we believe will redefine the industry standard for IOL quality and performance.” Visit the JJV booth to learn more – Pavilion 7, Floor 7.2 Booth #E112
Tags: intraocular lens
Latest Articles
Congress Symposium to Highlight Practice Management Issues

Read more...

Rising into Leadership

Accomplished female ophthalmologists offer advice and encouragement.

Read more...

Two-Step Procedure Shows Positive Results

Study reveals potentially useful prognostic factors in a large cohort of keratoconus patients.

Read more...

Programme Committee Provides Backbone of ESCRS Scientific Content

Congress programme reflects commitment to innovation and expertise.

Read more...

ESCRS IOL Power Calculator Accuracy

All seven formulas are accurate, but two stand out, study finds.

Read more...

A Second Look at the First IOL Implantation

The traditional hero and villain story might not have a bad guy after all.

Read more...

MIGS Masterclass to Offer Grand Rounds and Wet Labs in Barcelona

Read more...

Matching Technologies to Presbyopic Patient Needs

Ever-growing selection of IOLs requires careful screening.

Read more...

Bringing PROMs into the Intermediate Vision Equation

Quality of life tools need to consider modern treatment options.

Read more...

New Tool Calculates Patient Travel Carbon Footprint

Read more...